Cell MedX Corp. - FORM 10-Q - EX-32.2 - CERTIFICATION - October 15, 2015

Attached files

file filename
EX-32.1 - CERTIFICATION - Cell MedX Corp.ex321.htm
EX-10.27 - LOAN AGREEMENT AND NOTE PAYABLE DATED SEPTEMBER 28, 2015 AMONG CELL MEDX CORP., AND RICHARD N. JEFFS. - Cell MedX Corp.ex1027.htm
EX-10.26 - LOAN AGREEMENT AND NOTE PAYABLE DATED SEPTEMBER 24, 2015 AMONG CELL MEDX CORP., AND CITY GROUP LLC. - Cell MedX Corp.ex1026.htm
10-Q - 10-Q - Cell MedX Corp.form10q.htm
EX-10.25 - STOCK OPTION AGREEMENT DATED SEPTEMBER 23, 2015 AMONG CELL MEDX CORP. AND STEVEN H. BULWA. - Cell MedX Corp.ex1025.htm
EX-10.23 - LOAN AGREEMENT AND NOTE PAYABLE DATED SEPTEMBER 3, 2015 AMONG CELL MEDX CORP., AND RICHARD N. JEFFS. - Cell MedX Corp.ex1023.htm
EX-3.2 - CERTIFICATION - Cell MedX Corp.ex312.htm
EX-10.28 - EBALANCE PROTOTYPE DEVELOPMENT AGREEMENT DATED OCTOBER 1, 2015 AMONG CELL MEDX CORP., AND CLAUDIO TASSI. - Cell MedX Corp.ex1028.htm
EX-10.24 - CONSULTING AGREEMENT DATED SEPTEMBER 1, 2015 AMONG CELL MEDX CORP., AND STEVEN H. BULWA. - Cell MedX Corp.ex1024.htm
EX-31.1 - CERTIFICATION - Cell MedX Corp.ex311.htm
 
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
 
In connection with the Quarterly Report of Cell MedX Corp. (the “Company”) on Form 10-Q for the period ending August 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
 
 
 (1)   The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 
(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Dated: October 15, 2015
 
 
/s/ Yanika Silina
Yanika Silina
Chief Financial Officer
(Principal Accounting Officer)

 
 
 

Cell MedX Corp. Reports

Also read